Cited by 288

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Self-Rated Global Measure of the Frequency, Intensity, and Burden of Side Effects

WISNIEWSKI, STEPHEN R., RUSH, A. JOHN, BALASUBRAMANI, G. K., TRIVEDI, MADHUKAR H., NIERENBERG, ANDREW A.·2006·Journal of Psychiatric Practice

DOI 10.1097/00131746-200603000-00002

Open this paper in CoChat — free account

Abstract

No standard side-effect measure currently available can be easily used in clinical practice for patients receiving treatment for depression. The Frequency, Intensity, and Burden of Side Effects Rating (FIBSER) Scale was developed to document these three domains of side effects in patients treated in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) project. This article presents data on the reliability and validity of the FIBSER. The STAR*D prospectively enrolled 4,041 outpatients with nonpsychotic major depressive disorder (MDD) who were seeking medical care (as opposed to symptomatic volunteers recruited via advertisements). The patients were treated with citalopram. Clinical assessments, including the FIBSER, were completed at 2, 4, 6, 9, 12, and, if necessary, 14 weeks after enrollment. The FIBSER was shown to be reliable, with high correlations between observations taken a short time apart, and correlations decreasing as time between observations increased. There were also consistent relationships between items over time. The FIBSER has both face and construct validity. Thus, the FIBSER is a reliable and valid self-report measure of side effects in a population receiving treatment for depression. Although it does not measure the impact of specific side effects, it does measure three domains of impact: frequency, intensity, and burden of the side effects. Its brevity makes it a useful tool for routine clinical practice. These advantages are not available in other side-effect measures.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1097/00131746-200603000-00002

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

A 12-Item Short-Form Health Survey: Construction of Scales and Preliminary Tests of Reliability and Validity
WARE, J. E., KOSINSKI, M., & KELLER, S. D. (1996) · Medical Care · doi:10.1097/00005650-199603000-00003 · Cited by 17,392
The 16-item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression
Rush, A. J., Trivedi, M. H., Ibrahim, H. M., Carmody, T. J., Arnow, B., Klein, D. N., Markowitz, J. C., Ninan, P. T., Kornstein, S., Manber, R., et al. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01866-8 · Cited by 3,829
Self-citation
The Work and Social Adjustment Scale: a simple measure of impairment in functioning
Mundt, J. C., Marks, I. M., Shear, M. K., & Greist, J. M. (2002) · British Journal of Psychiatry · doi:10.1192/bjp.180.5.461 · Cited by 2,515
The UKU side effect rating scale: A new comprehensive rating scale for psychotropic drugs and a cross‐sectional study of side effects in neuroleptic‐treated patients
Lingjærde, O., Ahlfors, U. G., Bech, P., Dencker, S. J., & Elgen, K. (1987) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1987.tb10566.x · Cited by 1,705
The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation
TRIVEDI, M. H., RUSH, A. J., IBRAHIM, H. M., CARMODY, T. J., BIGGS, M. M., SUPPES, T., CRISMON, M. L., SHORES-WILSON, K., TOPRAC, M. G., DENNEHY, E. B., et al. (2004) · Psychological Medicine · doi:10.1017/s0033291703001107 · Cited by 968 · cited 3×
“Depressive symptom severity was assessed at each clinic visit using the Quick Inventory of Depressive Symptoms-Clinician Rated version (QIDS-C16 )21,22 administered by the CRC, as well as the Quick Inventory of Depressive SymptomsSelf-Report version (QIDS-SR16).(21,22) At each follow-up assessment, the Patient Rated I…”
MethodSelf-citation
Treating Depression in Alzheimer Disease: Efficacy and Safety of Sertraline Therapy, and the Benefits of Depression Reduction: The DIADS
Lyketsos, C. G., DelCampo, L., Steinberg, M., Miles, Q., Steele, C. D., Munro, C., Baker, A. S., Sheppard, J.-M. E., Frangakis, C., Brandt, J., et al. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.7.737 · Cited by 398

Show all 6 references

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
Self-citation
Difference in treatment outcome in outpatients with anxious versus nonanxious depression: A STAR*D report
Fava, M., Rush, A. J., Alpert, J. E., Balasubramani, G. K., Wisniewski, S. R., Carmin, C. N., Biggs, M. M., Zisook, S., Leuchter, A., Howland, R., et al. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06111868 · Cited by 927
Self-citation
The STAR*D project results: A comprehensive review of findings
Warden, D., Rush, A. J., Trivedi, M. H., Fava, M., & Wisniewski, S. R. (2007) · Current Psychiatry Reports · doi:10.1007/s11920-007-0061-3 · Cited by 727
Self-citation
Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report
Nierenberg, A. A., Husain, M. M., Trivedi, M. H., Fava, M., Warden, D., Wisniewski, S. R., Miyahara, S., & Rush, A. J. (2010) · Psychological Medicine · doi:10.1017/s0033291709006011 · Cited by 458
Self-citation
A 5-year observational study of patients with treatment-resistant depression treated with vagus nerve stimulation or treatment as usual: comparison of response, remission, and suicidality
Aaronson, S. T., Sears, P., Ruvuna, F., Bunker, M., Conway, C. R., Dougherty, D. D., Reimherr, F. W., Schwartz, T. L., & Zajecka, J. M. (2017) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2017.16010034 · Cited by 381
Cognitive Therapy Versus Medication in Augmentation and Switch Strategies as Second-Step Treatments: A STAR*D Report
Thase, M. E., Friedman, E. S., Biggs, M. M., Wisniewski, S. R., Trivedi, M. H., Luther, J. F., Fava, M., Nierenberg, A. A., McGrath, P. J., Warden, D., et al. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.5.739 · Cited by 332
Self-citation
Measurement-based care versus standard care for major depression: A randomized controlled trial with blind raters
Guo, T., Xiang, Y.-T., Xiao, L., Hu, C.-Q., Chiu, H. F. K., Ungvari, G. S., Correll, C. U., Lai, K. Y. C., Feng, L., Geng, Y., et al. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.14050652 · Cited by 308
Establishing moderators and biosignatures of antidepressant response in clinical care (EMBARC): Rationale and design
Trivedi, M. H., McGrath, P. J., Fava, M., Parsey, R. V., Kurian, B. T., Phillips, M. L., Oquendo, M. A., Bruder, G., Pizzagalli, D., Toups, M., et al. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.03.001 · Cited by 286
Self-citation
Can Phase III Trial Results of Antidepressant Medications Be Generalized to Clinical Practice? A STAR*D Report
Wisniewski, S. R., Rush, A. J., Nierenberg, A. A., Gaynes, B. N., Warden, D., Luther, J. F., McGrath, P. J., Lavori, P. W., Thase, M. E., Fava, M., et al. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08071027 · Cited by 223
Self-citation
Cognitive Behavioral Analysis System of Psychotherapy and Brief Supportive Psychotherapy for Augmentation of Antidepressant Nonresponse in Chronic Depression<subtitle>The REVAMP Trial</subtitle><alt-title>Augmentation With CBASP and BSP for Depression</alt-title>
Kocsis, J. H. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.144 · Cited by 214
Can C-reactive protein inform antidepressant medication selection in depressed outpatients? Findings from the CO-MED trial
Jha, M. K., Minhajuddin, A., Gadad, B. S., Greer, T., Grannemann, B., Soyombo, A., Mayes, T. L., Rush, A. J., & Trivedi, M. H. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.01.023 · Cited by 206
Self-citation
Safety, Tolerability, and Clinical Effect of Low-Dose Buprenorphine for Treatment-Resistant Depression in Midlife and Older Adults
Karp, J. F., Butters, M. A., Begley, A. E., Miller, M. D., Lenze, E. J., Blumberger, D. M., Mulsant, B. H., & Reynolds, C. F. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13m08725 · Cited by 191
Effect of Antidepressant Switching vs Augmentation on Remission Among Patients With Major Depressive Disorder Unresponsive to Antidepressant Treatment: The VAST-D Randomized Clinical Trial
Mohamed, S., Johnson, G. R., Chen, P., Hicks, P. B., Davis, L. L., Yoon, J., Gleason, T. C., Vertrees, J. E., Weingart, K., Tal, I., et al. (2017) · JAMA · doi:10.1001/jama.2017.8036 · Cited by 159
The International Study to Predict Optimized Treatment in Depression (iSPOT-D): Outcomes from the acute phase of antidepressant treatment
Saveanu, R., Etkin, A., Duchemin, A.-M., Goldstein-Piekarski, A., Gyurak, A., Debattista, C., Schatzberg, A. F., Sood, S., Day, C. V. A., Palmer, D. M., et al. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.12.018 · Cited by 151
Self-citation
Antidepressant side effects and their impact on treatment outcome in people with major depressive disorder: an iSPOT-D report
Braund, T. A., Tillman, G., Palmer, D. M., Gordon, E., Rush, A. J., & Harris, A. W. F. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01533-1 · Cited by 135
Self-citation
Effect of Sertraline on Depressive Symptoms in Patients With Chronic Kidney Disease Without Dialysis Dependence: The CAST Randomized Clinical Trial
Hedayati, S. S., Gregg, L. P., Carmody, T., Jain, N., Toups, M., Rush, A. J., Toto, R. D., & Trivedi, M. H. (2017) · JAMA · doi:10.1001/jama.2017.17131 · Cited by 129
“3; score range, 0-100; higher scores signify more favorable quality of life),(22) which were administered at baseline and at 6 and 12 weeks; (3) adverse events and tolerability assessed by the occurrence of serious adverse events (ie, death, dialysis initiation, hospitalizations, or bleeding requiring transfusion), ma…”
Self-citation
Effectiveness and acceptability of accelerated repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant major depressive disorder: An open label trial
McGirr, A., Van den Eynde, F., Tovar-Perdomo, S., Fleck, M. P. A., & Berlim, M. T. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.10.068 · Cited by 117
Emotion recognition processing as early predictor of response to 8‐week citalopram treatment in late‐life depression
Shiroma, P. R., Thuras, P., Johns, B., & Lim, K. O. (2014) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4104 · Cited by 110
Corticotropin-releasing factor receptor 1 antagonism is ineffective for women with posttraumatic stress disorder
Dunlop, B. W., Binder, E. B., Iosifescu, D., Mathew, S. J., Neylan, T. C., Pape, J. C., Carrillo-Roa, T., Green, C., Kinkead, B., Grigoriadis, D., et al. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.06.024 · Cited by 96
Pharmacogenetics Studies in STAR*D: Strengths, Limitations, and Results
Laje, G., Perlis, R. H., Rush, A. J., & McMahon, F. J. (2009) · Psychiatric Services · doi:10.1176/ps.2009.60.11.1446 · Cited by 89
Self-citation
Baseline depression severity as a predictor of single and combination antidepressant treatment outcome: Results from the CO-MED trial
Friedman, E. S., Davis, L. L., Zisook, S., Wisniewski, S. R., Trivedi, M. H., Fava, M., & Rush, A. J. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.07.010 · Cited by 81
“N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript groups with respect to early termination, response, remission, last FIBSER Burden, last QIDS-SR16 or percent of QIDS-SR16 reduction (Table 7).”
MethodInfluentialSelf-citation
Interleukin 17 selectively predicts better outcomes with bupropion-SSRI combination: novel T cell biomarker for antidepressant medication selection
Jha, M. K., Minhajuddin, A., Gadad, B. S., Greer, T. L., Mayes, T. L., & Trivedi, M. H. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2017.07.005 · Cited by 79
Self-citation
When Discontinuing SSRI Antidepressants Is a Challenge: Management Tips
Jha, M. K., Rush, A. J., & Trivedi, M. H. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2018.18060692 · Cited by 73
Self-citation
What I have learnt from helping thousands of people taper off antidepressants and other psychotropic medications
Framer, A. (2021) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125321991274 · Cited by 73
Does Duloxetine Improve Cognitive Function Independently of Its Antidepressant Effect in Patients with Major Depressive Disorder and Subjective Reports of Cognitive Dysfunction?
Greer, T. L., Sunderajan, P., Grannemann, B. D., Kurian, B. T., & Trivedi, M. H. (2014) · Depression Research and Treatment · doi:10.1155/2014/627863 · Cited by 63
Self-citation
VitalSign6: A Primary Care First (PCP-First) Model for Universal Screening and Measurement-Based Care for Depression
Trivedi, M., Jha, M., Kahalnik, F., Pipes, R., Levinson, S., Lawson, T., Rush, A., Trombello, J., Grannemann, B., Tovian, C., et al. (2019) · Pharmaceuticals · doi:10.3390/ph12020071 · Cited by 49
Self-citation
Evaluation of a corticotropin releasing hormone type 1 receptor antagonist in women with posttraumatic stress disorder: study protocol for a randomized controlled trial
Dunlop, B. W., Rothbaum, B. O., Binder, E. B., Duncan, E., Harvey, P. D., Jovanovic, T., Kelley, M. E., Kinkead, B., Kutner, M., Iosifescu, D. V., et al. (2014) · Trials · doi:10.1186/1745-6215-15-240 · Cited by 45
Low dose ketamine infusion for comorbid posttraumatic stress disorder and chronic pain: a randomized double-blind clinical trial
Dadabayev, A. R., Joshi, S. A., Reda, M. H., Lake, T., Hausman, M. S., Domino, E., & Liberzon, I. (2020) · Chronic Stress · doi:10.1177/2470547020981670 · Cited by 37
Correlates and outcomes of depressed out-patients with greater and fewer anxious symptoms: a CO-MED report
Chan, H. N., Rush, A. J., Nierenberg, A. A., Trivedi, M., Wisniewski, S. R., Balasubramani, G. K., Friedman, E. S., Gaynes, B. N., Davis, L., Morris, D., et al. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001660 · Cited by 30
Self-citation
Depression Outcomes of Spanish- and English-Speaking Hispanic Outpatients in STAR*D
Lesser, I., Zisook, S., Flores, D., Sciolla, A., Wisniewski, S., Cook, I., Epstein, M., Rosales, A., Gonzalez, C., Trivedi, M., et al. (2008) · Psychiatric Services · doi:10.1176/ps.2008.59.11.1273 · Cited by 27
Self-citation
Setting measurement‐based care in motion: practical lessons in the implementation and integration of measurement‐based care in psychiatry clinical practice
Martin-Cook, K., Palmer, L., Thornton, L., Rush, A. J., Tamminga, C. A., & Ibrahim, H. M. (2021) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s308615 · Cited by 25
Self-citation
Using Measurement Strategies to Identify and Monitor Residual Symptoms
McIntyre, R. S. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12084su1c.03 · Cited by 25
Proof‐of‐concept randomized controlled trial of single‐session nitrous oxide treatment for refractory bipolar depression: Focus on cerebrovascular target engagement
Kim, W. S. H., Dimick, M. K., Omrin, D., Mitchell, R. H. B., Riegert, D., Levitt, A., Schaffer, A., Belo, S., Iazzetta, J., Detzler, G., et al. (2023) · Bipolar Disorders · doi:10.1111/bdi.13288 · Cited by 24
A Randomized Evaluation of MoodFX, a Patient-Centred e-Health Tool to Support Outcome Measurement for Depression: Une évaluation randomisée de MoodFX, un outil de santé en ligne centré sur le patient pour soutenir la mesure du résultat dans la dépression.
Li, V. W., Sahota, J., Dev, D. K., Gill, D. D., Evans, V. C., Axler, A., Chakrabarty, T., Do, A., Keramatian, K., Nunez, J.-J., et al. (2024) · The Canadian Journal of Psychiatry · doi:10.1177/07067437241245331 · Cited by 8
What does “Staying well” After depression mean? Chronic low grade symptomatology after treatment for depression is common
Strege, M. V., Richey, J. A., & Siegle, G. J. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.08.075 · Cited by 8
Comparison of the Efficacy Between Standard Measurement-Base Care (MBC) and Enhanced MBC for Major Depressive Disorder: A Pilot Study
He, Y., Wang, X., Wang, Z., Zhang, P., Huang, X., Yu, M., Murphy, J., Michalak, E., Liu, J., Yang, T., et al. (2024) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s468332 · Cited by 5
Use of treatment services in a comparative effectiveness study of bipolar disorder
Sylvia, L. G., Iosifescu, D., Friedman, E. S., Bernstein, E. E., Bowden, C. L., Ketter, T. A., Reilly-Harrington, N. A., Leon, A. C., Calabrese, J. R., Ostacher, M. J., et al. (2013) · Psychiatric Services · doi:10.1176/appi.ps.201200479 · Cited by 3
Self-citation

Authors: WISNIEWSKI, S. R., RUSH, A. J., BALASUBRAMANI, G. K., TRIVEDI, M. H., & NIERENBERG, A. A.
Venue: Journal of Psychiatric Practice
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2006-03
Volume: 12
Issue: 2
Pages: 71-79
ISSN: 1527-4160 (ISSN-L)
1538-1145
DOI: 10.1097/00131746-200603000-00002
OpenAlex: W2073658384
Cited by: 288
References: 6
FWCI: 9.62
Type: journal article
Language: en
Open access: closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

Self-Rated Global Measure of the Frequency, Intensity, and Burden of Side Effects

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Metadata

Record

About these checks

Data sources